AN ACT PERMITTING EMERGENCY MEDICAL TECHNICIANS TO ADMINISTER INTRANASAL GLUCAGON.
SB 257 permits emergency medical technicians (EMTs) to administer intranasal glucagon for severe low blood sugar (hypoglycemia), aligning with how they currently use opioid antagonists like naloxone. This change directly affects EMTs who respond to medical emergencies and patients experiencing acute hypoglycemia, such as those with diabetes. The bill modifies existing statutes to allow EMTs to use this non-invasive treatment method without additional authorization. It does not create new requirements but expands EMTs’ existing emergency response toolkit. The bill focuses solely on enabling this specific medical intervention during critical incidents.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 8, 2025
Last action Jan 8, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
1
Jan 8, 2025
Committee
REF. TO JOINT COMM. ON Public Health
upper
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 257
Scope: CT
Hi! I can help you understand SB 257. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline